Perspectives And Outcomes Associated With The Convergence Procedure - A Data Review
Goya V. Raikar.
Crossway Medical Clinic, oklahoma city, OK, USA.
Atrial fibrillation (A Fib) remains the most common cardiac arrhythmia affecting approximately 33.5 million individuals worldwide. Many of these patients will fall into the “difficult to treat” subset and often face an uncertain future. Uncontrolled or untreated A Fib can lead to blood clots, stroke, heart failure and other cardiac related complications.
In today’s medical world there are several treatment options for A Fib. While medications followed by endovascular surgeries are often the starting point, for patients who fail these treatments, the Convergent Procedure may be the best option to treat their persistent A-Fib. The Convergent procedure merges the best from Electrophysiology and cardiothoracic surgery to produce to best results within this patient population.
The Convergent procedure is a closed chest procedure with a minimally invasive abdominal incision. This allows for a shorter stay in the hospital along with a faster recovery period.
The purpose of this presentation is to share with the participants the results of a convenience sample from 212 atrial fib patients who had the convergent procedure in a specialty hospital located in Oklahoma City, Oklahoma in the United States
Although multiple data points were reviewed from the sample, the main endpoints of this study were:
1. Following the Convergence procedure, how long does the patient remain in normal sinus rhythm (versus return to A Fib)
2. Did the Convergence procedure allow a decrease in the usage of anti-coagulants.
Of the 212 patients within our sample, 199 (94%) remained within normal sinus (A Fib free) for greater than 2 years. This data was captured by a real-time loop placed at the time of procedure.
When reviewing the data on anti-coagulants, 205 of the 212 patients (97%) of the sample remained off anti-coagulants for greater than two years.
When looking at treatment options for uncontrolled A Fib, the Convergence Procedure remains a strong option for this subset of patients. While these results are positive, future research is necessary to help solidify the Convergence Procedure as the new gold standard for uncontrolled A Fib patients.
Back to 2017 Posters